BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33319736)

  • 41. Certolizumab for the treatment of localized pyoderma gangrenosum associated with Crohn's disease: A case report.
    Pender TM; Ayandibu G; Van Voorhees AS
    Dermatol Ther; 2020 Nov; 33(6):e14352. PubMed ID: 32981217
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of pyoderma gangrenosum associated with Crohn's disease.
    Ohmori T; Yamagiwa A; Nakamura I; Nishikawa K; Saniabadi AR
    Am J Gastroenterol; 2003 Sep; 98(9):2101-2. PubMed ID: 14499797
    [No Abstract]   [Full Text] [Related]  

  • 43. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scrotal pyoderma gangrenosum associated with Crohn's disease.
    Ho SA; Tan WP; Tan AW; Wong SN; Chua SH
    Singapore Med J; 2009 Dec; 50(12):e397-400. PubMed ID: 20087538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cutaneous leishmaniasis in rheumatoid arthritis].
    Hachicha I; Sellami M; Fourati H; Akrout R; Hdiji N; Baklouti S
    Rev Med Interne; 2009 Jul; 30(7):609-12. PubMed ID: 19285366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crohn Disease Presenting as the Cutaneous Rash of Pyoderma Gangrenosum.
    Harris CA; Lehto EM; Laneiwcz MB
    Pediatr Emerg Care; 2020 Oct; 36(10):e585-e588. PubMed ID: 32925696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum.
    Altunay I; Kucukunal A; Sarikaya S; Tukenmez Demirci G
    Int Wound J; 2014 Aug; 11(4):350-3. PubMed ID: 23106966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrointestinal: A rare case of concurrent vulvar Crohn's disease and pyoderma gangrenosum.
    Bommireddipally J; Broussard K; Osman H; Uhlhorn A; Loganantharaj N
    J Gastroenterol Hepatol; 2024 Mar; 39(3):417-419. PubMed ID: 38030955
    [No Abstract]   [Full Text] [Related]  

  • 50. Peristomal cutaneous Crohn's disease by contiguity.
    Palomar Ávila C; Moreno Pimentel C; Masero Carretero JM; Coca López M
    Rev Esp Enferm Dig; 2023 Aug; 115(8):454-455. PubMed ID: 35791785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.
    Avilés-Izquierdo JA; Suárez-Fernández R; Lázaro-Ochaita P; Longo-Imedio I
    Acta Derm Venereol; 2005; 85(1):60-2. PubMed ID: 15848994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease.
    Gellert A; Green ES; Beck ER; Ridley CM
    Postgrad Med J; 1983 Dec; 59(698):791-3. PubMed ID: 6657543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Complex cutaneous Leishmaniasis from the "Old World" : Therapeutic challenges in two complicated disease courses].
    Gebhardt M; Völker K; Vanegas Ramirez A; Edler C; Fischer M
    Hautarzt; 2020 Jun; 71(6):437-442. PubMed ID: 32394080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissemination of localized cutaneous leishmaniasis in an organ transplant recipient: case report and literature review.
    Zandieh A; Zandieh B; Dastgheib L
    Int J Dermatol; 2013 Jan; 52(1):59-62. PubMed ID: 23278609
    [No Abstract]   [Full Text] [Related]  

  • 55. Surgical management of pyoderma gangrenosum: case report and review.
    Alam M; Grossman ME; Schneiderman PI; Blume RS; Benvenisty AI
    Dermatol Surg; 2000 Nov; 26(11):1063-6. PubMed ID: 11096397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of the relationship between pyoderma gangrenosum and Crohn's disease: a population-based case-control study.
    Kridin K; Damiani G; Ludwig RJ; Tzur-Bitan D; Cohen AD
    Scand J Gastroenterol; 2020 Jul; 55(7):814-818. PubMed ID: 32634344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyoderma gangrenosum as a first presentation of inflammatory bowel disease.
    Shahid S; Myszor M; De Silva A
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25385558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
    Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
    J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyoderma gangrenosum in a patient with collagenous colitis.
    Batra AK; Levey JM; Trister J; Patwardhan R
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S277-9. PubMed ID: 14576653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.